HER2 Support Group Forums - View Single Post

07-22-2003, 04:40 AM

A recent study published in the Clinical Breast Cancer Journal found that the increased rate of brain metastasis with trastuzumab (Herceptin) therapy is not associated with impaired survival.

07-22-2003, 04:40 AM	#1
Paul C. Guest Posts: n/a	A recent study published in the Clinical Breast Cancer Journal found that the increased rate of brain metastasis with trastuzumab (Herceptin) therapy is not associated with impaired survival.